New therapy for glioma receives FDA approval, leveraging cancer research conducted at Johns Hopkins & Duke University

Drs. Darell Bigner and Hai Yan (Neurosurgery, SOM) and colleagues identified the genetic mutation targeted by this new drug. Dr. Katherine Peters (Neurosurgery, SOM) was lead investigator in the clinical trials.